Cargando…

Pathophysiology and Management of Cardiovascular Disease in HIV-Infected Patients

A number of studies suggest that HIV-infected individuals have an elevated risk of cardiovascular disease (CVD), especially coronary heart disease, compared to the HIV-uninfected population. People living with HIV have an increased prevalence of traditional CVD risk factors but HIV-specific mechanis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nou, Eric, Lo, Janet, Hadigan, Colleen, Grinspoon, Steven K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4921313/ https://www.ncbi.nlm.nih.gov/pubmed/26873066 http://dx.doi.org/10.1016/S2213-8587(15)00388-5

Ejemplares similares

Statin Effects to Reduce Hepatosteatosis as Measured by Computed Tomography in Patients With Human Immunodeficiency Virus
por: Lo, Janet, et al.
Publicado: (2016)

Statins for primary cardiovascular disease prevention among people with HIV: emergent directions
por: Fitch, Kathleen V., et al.
Publicado: (2022)

Type 2 Diabetes and Impaired Glucose Tolerance in Two Young Adults Infected With HIV Early in Life
por: Dimock, David, et al.
Publicado: (2011)

A1C Underestimates Glycemia in HIV Infection
por: Kim, Peter S., et al.
Publicado: (2009)

Aspirin Use for Primary and Secondary Prevention in Human Immunodeficiency Virus (HIV)-Infected and HIV-Uninfected Patients
por: Suchindran, Sujit, et al.
Publicado: (2014)

Determinants of Smoking and Quitting in HIV-Infected Individuals
por: Regan, Susan, et al.
Publicado: (2016)

Effects of tesamorelin on hepatic transcriptomic signatures in HIV-associated NAFLD
por: Fourman, Lindsay T., et al.
Publicado: (2020)

IL-27 Modulates the Cytokine Secretion in the T Cell–Osteoclast Crosstalk During HIV Infection
por: Li, Tong, et al.
Publicado: (2022)

Delineating tesamorelin response pathways in HIV-associated NAFLD using a targeted proteomic and transcriptomic approach
por: Fourman, Lindsay T., et al.
Publicado: (2021)

Increased Prevalence of Albuminuria in HIV-Infected Adults with Diabetes
por: Kim, Peter S., et al.
Publicado: (2011)

Relationship Between Neck Circumference and Cardiometabolic Parameters in HIV-Infected and non–HIV-Infected Adults
por: Fitch, Kathleen V., et al.
Publicado: (2011)

Longterm Evaluation of Hemoglobin A1c Following Hepatitis C Therapy in Patients with and without HIV Co-infection
por: Chaudhury, Chloe, et al.
Publicado: (2017)

Every Minute Counts—The Time Is Now to Understand Predictors of Stroke in HIV
por: Srinivasa, Suman, et al.
Publicado: (2019)

Coronary vessel wall thickening in asymptomatic young HIV-infected patients vs. controls using phase-sensitive dual inversion recovery (PS-DIR) MRI
por: Abd-Elmoniem, Khaled Z, et al.
Publicado: (2013)

Sarcopenic obesity: epidemiology, pathophysiology, cardiovascular disease, mortality, and management
por: Wei, Shibo, et al.
Publicado: (2023)

Pathophysiology and pharmacology of cardiovascular disease
por: Selvaraj, Raja J.
Publicado: (2016)

Pathophysiology, pharmacotherapy, cardiovascular disease
por: Sharma, Kamal H.
Publicado: (2015)

The Role of Inflammation and Immune Activation on Circulating Endothelial Progenitor Cells in Chronic HIV Infection
por: Zhu, Ziang, et al.
Publicado: (2021)

Growth Hormone Releasing Hormone Reduces Plasma Markers of Immune Activation and Hepatic Immune Pathways in Nonalcoholic Fatty Liver Disease
por: Stanley, Takara Leah, et al.
Publicado: (2021)

Assessing statin effects on cardiovascular pathways in HIV using a novel proteomics approach: Analysis of data from INTREPID, a randomized controlled trial
por: Toribio, Mabel, et al.
Publicado: (2018)

Pathophysiological concepts and screening of cardiovascular disease in dialysis patients
por: Echefu, Gift, et al.
Publicado: (2023)

Role of miRNAs on the Pathophysiology of Cardiovascular Diseases
por: da Silva, Debora Cristina Pereira, et al.
Publicado: (2018)

Pathophysiology and pharmacological management of pulmonary and cardiovascular features of COVID-19
por: Hamouche, Walid, et al.
Publicado: (2021)

Obesity phenotypes and cardiovascular risk: From pathophysiology to clinical management
por: Preda, Alberto, et al.
Publicado: (2023)

Differential relationships of hepatic and epicardial fat to body composition in HIV
por: Fourman, Lindsay T., et al.
Publicado: (2017)

Comparison of visceral fat measurement by dual-energy X-ray absorptiometry to computed tomography in HIV and non-HIV
por: Fourman, Lindsay T., et al.
Publicado: (2019)

Ideal cardiovascular health, biomarkers, and coronary artery disease in persons with HIV
por: Douglas, Pamela S., et al.
Publicado: (2023)

Actions of Retinoic Acid in the Pathophysiology of HIV Infection
por: Sidell, Neil, et al.
Publicado: (2022)

Pathophysiology and Classification of Cardiovascular Diseases Caused by Atherosclerosis
por: Reiner, Željko
Publicado: (2003)

Influenza and cardiovascular disease pathophysiology: strings attached
por: Skaarup, Kristoffer Grundtvig, et al.
Publicado: (2023)

HIV Infection and Cardiovascular Disease
por: Fuchs, Sandra C., et al.
Publicado: (2013)

Pathophysiology of CD4+ T-Cell Depletion in HIV-1 and HIV-2 Infections
por: Vidya Vijayan, K. K., et al.
Publicado: (2017)

Proprotein Convertase Subtilisin/Kexin 9 Levels in Relation to Systemic Immune Activation and Subclinical Coronary Plaque in HIV
por: Zanni, Markella V, et al.
Publicado: (2017)

The role of epicardial adipose tissue dysfunction in cardiovascular diseases: an overview of pathophysiology, evaluation, and management
por: Li, Cheng, et al.
Publicado: (2023)

1499. Tesamorelin Reduces Visceral Adipose Tissue and Liver Fat in INSTI-Treated Persons with HIV
por: McLaughlin, Taryn, et al.
Publicado: (2023)

Postprandial Dyslipidemia: Pathophysiology and Cardiovascular Disease Risk Assessment
por: Higgins, Victoria, et al.
Publicado: (2017)

Mitochondrial Dysfunction and Cardiovascular Disease: Pathophysiology and Emerging Therapies
por: Stamerra, Cosimo Andrea, et al.
Publicado: (2022)

Infections as Novel Risk Factors of Atherosclerotic Cardiovascular Diseases: Pathophysiological Links and Therapeutic Implications
por: Szwed, Piotr, et al.
Publicado: (2021)

Non-Alcoholic Fatty Liver Disease and Cardiovascular Comorbidities: Pathophysiological Links, Diagnosis, and Therapeutic Management
por: Jichitu, Alexandra, et al.
Publicado: (2021)

Myeloma bone disease: Pathophysiology and management
por: Silbermann, Rebecca, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_avjpa4pq18f829fnus95au8nqc